Europe — EMA

Oxaliplatin Accord

Request sourcing

Pack/s

What is Oxaliplatin?

Oxaliplatin, the active ingredient in Oxaliplatin Accord, is a platinum‑based chemotherapy presented as a strength/form for intravenous use. It treats colorectal cancer and related solid tumours in adult patients. GNH USA supplies Oxaliplatin Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

GNH USA supplies Oxaliplatin Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

What is Oxaliplatin used for?

Oxaliplatin Accord is used in the treatment of cancers that are part of the colorectal cancer pathway.

- Colorectal cancer: Improves survival and reduces tumour growth in metastatic disease. - Gastric cancer: Used as part of combination regimens to shrink tumours in advanced cases. - Pancreatic ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... - ... ... ... - ... ... ... - ... ... exact

What are the side effects of Oxaliplatin?

This … ... ... … the … … … … … ....

What precautions apply to Oxaliplatin?

...

What does Oxaliplatin interact with?

{}

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →